Copyright
©The Author(s) 2017.
World J Transplant. Oct 24, 2017; 7(5): 269-275
Published online Oct 24, 2017. doi: 10.5500/wjt.v7.i5.269
Published online Oct 24, 2017. doi: 10.5500/wjt.v7.i5.269
Predictor | Univariate analysis | Multivariate analysis | ||||
PyVAN negative (n = 272) | PyVAN positive (n = 47) | P value | OR | CI | P value | |
Age (mean, yr) | 51 | 53.1 | 0.343 | |||
Male | 177 | 33 | 0.493 | |||
Black race | 67 | 19 | 0.024a | 1.68 | 0.86-3.31 | 0.13 |
Diabetes mellitus | 71 | 15 | 0.407 | |||
CMV D+/R- | 49 | 9 | 0.839 | |||
DDKT | 140 | 34 | 0.008a | 2.24 | 1.1-4.54 | 0.03a |
Thymoglobulin | 97 | 21 | 0.237 | |||
Basiliximab | 124 | 19 | 0.511 | |||
Daclizumab | 50 | 6 | 0.412 | |||
Delayed graft function | 47 | 11 | 0.315 | |||
Acute rejection | 44 | 15 | 0.010a | 2.42 | 1.19-4.29 | 0.02a |
Graft loss | 13 | 4 | ||||
Death | 16 | 6 | 0.112 |
- Citation: Azar MM, Assi R, Valika AK, Banach DB, Hall IE, Landry ML, Malinis MF. Graft loss among renal-transplant recipients with early reduction of immunosuppression for BK viremia. World J Transplant 2017; 7(5): 269-275
- URL: https://www.wjgnet.com/2220-3230/full/v7/i5/269.htm
- DOI: https://dx.doi.org/10.5500/wjt.v7.i5.269